Platinum complexes of antitumor agents
US4544759A · kind A · utility
13Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 1983 |
| Grant date | Oct 1, 1985 |
| Priority date | — |
| Expiry date | Jul 29, 2003 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F15/0093
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The compounds are the class of substituted hydrazine carboximidamides which are useful for inducing the regression and/or palliation of leukemia and related cancers in mammals when administered in amounts of from about one mg. to about 1.2 gm. per square meter of body surface area per day.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.